Fitz Bits: Wait for a Retest in Ford (RealMoney.com $)
I'd be a buyer if the stock holds up at $8.
11:00AM 11/23/09
Going Shopping (Deep in the Money Calls $)
This high-quality retail name has experienced a nice pullback and is more likely to bounce than fall further.
09:35AM 11/20/09
Genentech, Biogen Get FDA Request On Rituxan
Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia
04:48PM 11/18/09
All That Glitters Is Not Gold (Deep in the Money Calls $)
Sometimes it's silver, as this strong performer in the precious-metals sector illustrates.
10:04AM 11/18/09
Genzyme's Termeer: Worst Biotech CEO of '09
Genzyme CEO Henri Termeer is Adam Feuerstein's Worst Biotech CEO of the Year for 2009.
12:31PM 11/17/09
Practicing Balance With P&G: China Watch
By Stephanie Link | By Brittany Umar
NEW YORK -- Stephanie Link, director of research for Action Alerts PLUS, explains why she is still such a fan of Procter & Gamble and why this stock could be a perfect balance for your China portfolio.
05:00AM 11/09/09
Betting on an Industrial Juggernaut (Deep in the Money Calls $)
This company is benefiting from excellent management and a good mix of products that will do well in this economy. Also, updating prior stock picks.
09:38AM 11/06/09
Alnylam Takes Wider Loss On Administrative Costs
Alnylam says 3Q loss deepened as revenue edged lower and administrative spending increased
05:13PM 11/04/09
Human Genome Calls Second Lupus Drug Study a Success
Benlysta did not perform as well as in first pivotal study.
05:52AM 11/02/09
Biotech Mailbag: The Reason(s) for This Selloff
Readers asks why the sector is fading and seek insight on Gilead, Oncothyreon, ImmunoGen and more.
07:00AM 10/30/09
More PML Troubles for Biogen, Elan MS Drug: Biobuzz
European regulators update reports of serious brain infection tied to Tysabri.
10:25AM 10/29/09
Good News and Bad News (Top Stocks $)
The market should soon reach an oversold reading, though a number of bearish developments are also cropping up.
07:30PM 10/27/09
Midday Movers: Pump Up the Volume
Several small-cap stocks were moving on above-average volume during Friday's session
02:50PM 10/23/09
Biogen, Elan Fall on Brain Infection Fears
Biogen and Elan shares fall as European regulators investigate Tysabri brain infection reports.
11:32AM 10/23/09



Connect with TheStreet